GC 2022 Presentations
FRIDAY – 28th October 2022
Welcome Address by the European Commission
European Commission, DG Health and Food Safety
Unit C2 – State of Health, European Semester, Health Technology Assessment, Brussels
SATURDAY – 29th October 2022
Special Day Celebrating the Rich History of the IFCC Organization
Welcome and Opening of the General Conference
Co-Chairs: Khosrow Adeli & David Kinniburgh
IFCC: Emerging Stronger Post-Pandemic
SESSION 1
IFCC PAST PRESIDENTS SYMPOSIUM:
70 Years of Global Leadership in Laboratory Medicine
IFCC: A Glorious History of Global Cooperation & Major Scientific/Educational Advances
Moderator: Prof. Khosrow Adeli
SESSION 2
IFCC REGIONAL FEDERATION PRESIDENTS SYMPOSIUM:
History and Major Achievements of Regional Federations Around the World
Moderator: Dr. Alexander Haliassos
- Prof Tomris Ozben (EFLM)
- Prof Rajiv Erasmus (AFCC)
- Dr. Alvaro Justiniano Grosz/Dr. Ana Lena (COLABIOCLI)
- Dr. Osama Najjar (AFCB)
- Dr. Stephen Hill (NAFCC)
- Dr. Endang Hoyaranda (APFCB)
SESSION 3
IFCC 70TH ANNIVERSARY SYMPOSIUM
Central Role of Lab Medicine in Patient Care & Public Health – A Look into the Future
Moderator: Dr. David Kinniburgh
- Khosrow Shotorbani (Lab 2.0) CEO, Project Santa Fe Foundation/Founder, Lab 2.0 Strategic Services
Role of the clinical laboratory in future era of healthcare as we transition from volume to value
- Dr. David Grenache (AACC) Chief Scientific Officer, TriCore Reference Laboratories
Laboratory Director/Clinical Professor of Pathology, University of New Mexico
How we harnessed laboratory data to improve health and economic outcomes
- Dr. Francis Moussy (WHO) Lead, Secretariat of the WHO Model List of Essential IVD (the EDL) World Health Organization, WHO – Geneva, Switzerland
The WHO Model List of Essential In Vitro Diagnostics
- Prof Christa Cobbaert (IVDR) Vice-Chair, IFCC Scientific Division; Clinical Chemistry & Laboratory Medicine, Leiden University Medical Center; Leiden, the Netherlands
Critical implications of the IVDR roll out for Continuation and Innovation in Diagnostics
SESSION 4
INDUSTRY FORUM: THE FUTURE OF IVD OVER THE NEXT DECADE
Moderators: Tricia Ravalico (Abbott) and Joseph Passarelli (Roche)
- Anne Skurup Senior Medical Advisor, Radiometer Medical; Denmark
Meeting the demand for clinical studies for regulatory approval: how can IFCC and the IVD industry collaborate to meet the need?
- Dr. Frank Vitzthum Siemens Healthcare Diagnostics Products GmbH, Managing Director; Germany
Emerging trends
- Els Melis EMA Senior Marketing Manager, QuidelOrtho, Belgium
What have we learned from the experience of COVID
- Brendan Meyer Associate Director, Medical Affairs EMEA, Integrated Diagnostic Solutions, Becton Dickinson Life Sciences; United Kingdom
IVD industry partnership with IFCC
SUNDAY – 30th October 2022
SESSION 1
IFCC Functional Groups - Reports & Future Plans/Vision
IFCC EXECUTIVE BOARD PRESENTATIONS – OVERVIEW
Co-Chairs: Khosrow Adeli & David Kinniburgh
Finance Report
Corporate Members Report
SCIENTIFIC DIVISION (SD)
SESSION 2
EDUCATION & MANAGEMENT DIVISION (EMD)
EMERGING TECHNOLOGY DIVISION (ETD)
SESSION 3
COMMUNICATIONS & PUBLICATIONS DIVISION (CPD)
CONFERENCES & CONGRESSES COMMITTEE (C-CC)
NEW IFCC TASK FORCES/PROJECTS
TF Global Newborn Screening (TF-NBS)
TF Global Lab Quality (TF-GLQ )
SESSION 4
NEW IFCC TASK FORCES/PROJECTS
TF Global Reference Interval Database (TF-GRID)
TF Outcome Studies in Lab Med (TF-OSLM)
TF Global eLearning/eAcademy (TF-GEL)
SUMMARY REMARKS
Outcomes of the GC & new directions for the IFCC